{"id":"tp-38990","type":"article-newspaper","title":"FDA Approves New Roche Drug Uses for Cancer, Kidney and Eye Diseases","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/38990","datePublished":"2026-10-23T13:06:19.000Z","dateModified":"2026-10-23T13:06:19.000Z","language":"en","abstract":"The Oct. 8 Tecentriq decision covers a chemotherapy combination for certain stage III colon cancers; Enspryng was cleared for adults with thyroid eye disease on Oct. 15.","section":"Regulation","references":[]}